Vitamin D, leptin and impact on immune response to seasonal influenza A/H1N1 vaccine in older persons

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 3, 2016, Pages 691-698

  Sadarangani, Sapna P ^a,b   Ovsyannikova, Inna G ^a   Goergen, Krista ^b   Grill, Diane E ^b   Poland, Gregory A ^a  

^a Mayo Vaccine Research Group   (United States)

^b MAYO CLINIC   (United States)

Author keywords

H1N1 subtype; influenza A virus; influenza vaccines; leptin; receptors; vitamin D; vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; GRANZYME B; INFLUENZA VACCINE; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; VITAMIN D;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BODY MASS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; ENZYME ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; GENE; GENOTYPE; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNOSENESCENCE; INFLUENZA A (H1N1); LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE; SEASONAL INFLUENZA; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM MASS SPECTROMETRY; VIRUS NEUTRALIZATION; ADAPTIVE IMMUNITY; BLOOD; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); MINNESOTA; NORMAL HUMAN; RETROSPECTIVE STUDY;

ADAPTIVE IMMUNITY; AGED; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MALE; MIDDLE AGED; MINNESOTA; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; RETROSPECTIVE STUDIES; VITAMIN D;

EID: 84976482366     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1097015     Document Type: Article

References (58)

1. A.E.Fiore, T.M.Uyeki, K.Broder, L.Finelli, G.L.Euler, J.A.Singleton, J.K.Iskander, P.M.Wortley, D.K.Shay, J.S.Bresee, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR RecommRep 2010; 59:1-62
2. T.M.Govaert, C.T.Thijs, N.Masurel, M.J.Sprenger, G.J.Dinant, J.A.Knottnerus. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272:1661-5; PMID:7966893; http://dx.doi.org/10.1001/jama.1994.03520210045030
3. K.Goodwin, C.Viboud, L.Simonsen. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24:1159-69; PMID:16213065; http://dx.doi.org/10.1016/j.vaccine.2005.08.105
4. P.O.Lang, S.Govind, W.A.Mitchell, N.Kenny, A.Lapena, D.Pitts, R.Aspinall. Influenza vaccine effectiveness in aged individuals: The role played by cell-mediated immunity. Eur Geriatric Med 2010; 1:233-8; http://dx.doi.org/10.1016/j.eurger.2010.07.002
5. P.A.Sheridan, H.A.Paich, J.Handy, E.A.Karlsson, M.G.Hudgens, A.B.Sammon, L.A.Holland, S.Weir, T.L.Noah, M.A.Beck. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obesity 2012; 36:1072-7; http://dx.doi.org/10.1038/ijo.2011.208
6. A.J.Stoppelenburg, J.H.von Hegedus, R.Huis in't Veld, L.Bont, M.Boes. Defective control of vitamin D receptor-mediated epithelial STAT1 signalling predisposes to severe respiratory syncytial virus bronchiolitis. J Path 2014; 232:57-64; PMID:24105653; http://dx.doi.org/10.1002/path.4267
7. R.Bellamy, C.Ruwende, T.Corrah, K.P.McAdam, M.Thursz, H.C.Whittle, A.V.Hill. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179:721-4; PMID:9952386; http://dx.doi.org/10.1086/314614
8. J.M.Zmuda, J.A.Cauley, R.E.Ferrell. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000; 22:203-17; PMID:11218372; http://dx.doi.org/10.1093/oxfordjournals.epirev.a018033
9. M.E.Sundaram, H.K.Talbot, Y.Zhu, M.R.Griffin, S.Spencer, D.K.Shay, L.A.Coleman. Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old. Vaccine 2013; 31:2057-61; PMID:23453766; http://dx.doi.org/10.1016/j.vaccine.2013.02.028
10. C.Cooper, A.Thorne. Vitamin D supplementation does not increase immunogenicity of seasonal influenza vaccine in HIV-infected adults. HIV Clin Trials 2011; 12:275-6; PMID:22180525; http://dx.doi.org/10.1310/hct1205-275
11. M.K.Chadha, M.Fakih, J.Muindi, L.Tian, T.Mashtare, C.S.Johnson, D.Trump. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate 2011; 71:368-72; PMID:20812224; http://dx.doi.org/10.1002/pros.21250
12. N.Principi, P.Marchisio, L.Terranova, A.Zampiero, E.Baggi, C.Daleno, S.Tirelli, C.Pelucchi, S.Esposito. Impact of vitamin D administration on immunogenicity of trivalent inactivated influenza vaccine in previously unvaccinated children. Hum Vaccin Immunother 2013; 9:969-74; PMID:23324599; http://dx.doi.org/10.4161/hv.23540
13. J.A.Antonen, P.M.Hannula, R.Pyhala, H.H.Saha, I.O.Ala-Houhala, A.I.Pasternack. Adequate seroresponse to influenza vaccination in dialysis patients. Nephron 2000; 86:56-61; PMID:10971154; http://dx.doi.org/10.1159/000045713
14. C.J.Rosen, J.S.Adams, D.D.Bikle, D.M.Black, M.B.Demay, J.E.Manson, M.H.Murad, C.S.Kovacs. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 2012; 33:456-92; PMID:22596255; http://dx.doi.org/10.1210/er.2012-1000
15. S.Christakos, M.Hewison, D.G.Gardner, C.L.Wagner, I.N.Sergeev, E.Rutten, A.G.Pittas, R.Boland, L.Ferrucci, D.D.Bikle. Vitamin D: beyond bone. Ann NY Acad Sci 2013; 1287:45-58; PMID:23682710; http://dx.doi.org/10.1111/nyas.12129
16. C.Ding, V.Parameswaran, L.Blizzard, J.Burgess, G.Jones. Not a simple fat-soluble vitamin: Changes in serum 25-(OH)D levels are predicted by adiposity and adipocytokines in older adults. J Intern Med 2010; 268:501-10; PMID:20804516; http://dx.doi.org/10.1111/j.1365-2796.2010.02267.x
17. S.J.White, M.J.Taylor, R.T.Hurt, M.D.Jensen, G.A.Poland. Leptin-based adjuvants: an innovative approach to improve vaccine response. Vaccine 2013; 31:1666-72; PMID:23370154; http://dx.doi.org/10.1016/j.vaccine.2013.01.032
18. I.G.Ovsyannikova, S.J.White, B.R.Larrabee, D.E.Grill, R.M.Jacobson, G.A.Poland. Leptin and leptin-related gene polymorphisms, obesity, and influenza A/H1N1 vaccine-induced immune responses in older individuals. Vaccine 2014; 32:881-7; PMID:24360890; http://dx.doi.org/10.1016/j.vaccine.2013.12.009
19. R.M.Jacobson, D.E.Grill, A.L.Oberg, P.K.Tosh, I.G.Ovsyannikova, G.A.Poland. Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers. Hum Vaccin Immunother 2015; 11:961-9; PMID:25835513; http://dx.doi.org/10.1080/21645515.2015.1011990
20. J.M.Katz, J.Plowden, M.Renshaw-Hoelscher, X.Lu, T.M.Tumpey, S.Sambhara. Immunity to influenza: the challenges of protecting an aging population. Immunol Res 2004; 29:113-24; PMID:15181275; http://dx.doi.org/10.1385/IR:29:1-3:113
21. C.Franceschi, M.Bonafe, S.Valensin, F.Olivieri, L.M.De, E.Ottaviani, B.G.De. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000; 908:244-54; PMID:10911963; http://dx.doi.org/10.1111/j.1749-6632.2000.tb06651.x
22. B.Schottker, R.Jorde, A.Peasey, B.Thorand, E.H.Jansen, L.Groot, M.Streppel, J.Gardiner, J.M.Ordonez-Mena, L.Perna, et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 2014; 348:g3656; PMID:24938302; http://dx.doi.org/10.1136/bmj.g3656
23. S.Chen, G.P.Sims, X.X.Chen, Y.Y.Gu, P.E.Lipsky. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179:1634-47; PMID:17641030; http://dx.doi.org/10.4049/jimmunol.179.3.1634
24. D.D.Bikle D.Vitamin: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab 2010; 21:375-84; PMID:20149679; http://dx.doi.org/10.1016/j.tem.2010.01.003
25. M.R.Haussler, G.K.Whitfield, I.Kaneko, C.A.Haussler, D.Hsieh, J.C.Hsieh, P.W.Jurutka. Molecular mechanisms of vitamin D action. Calcified Tissue International 2013; 92:77-98; PMID:22782502; http://dx.doi.org/10.1007/s00223-012-9619-0
26. J.D.Kriesel, J.Spruance. Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 1999; 17:1883-8; PMID:10217585; http://dx.doi.org/10.1016/S0264-410X(98)00476-9
27. J.E.McElhaney, C.Ewen, X.Zhou, K.P.Kane, D.Xie, W.D.Hager, M.B.Barry, A.Kleppinger, Y.Wang, R.C.Bleackley. Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009; 27:2418-25; PMID:19368783; http://dx.doi.org/10.1016/j.vaccine.2009.01.136
28. H.M.Salk, I.H.Haralambieva, I.G.Ovsyannikova, K.M.Goergen, G.A.Poland. Granzyme B ELISPOT assay to measure influenza-specific cellular immunity. J Immunol Methods 2013; 398–399:44-50; PMID:24055591; http://dx.doi.org/10.1016/j.jim.2013.09.007
29. E.A.Karlsson, P.A.Sheridan, M.A.Beck. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J Immunol 2010; 184:3127-33; PMID:20173021; http://dx.doi.org/10.4049/jimmunol.0903220
30. C.P.Earthman, L.M.Beckman, K.Masodkar, S.D.Sibley. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obesity 2012; 36:387-96; http://dx.doi.org/10.1038/ijo.2011.119
31. K.S.Vimaleswaran, D.J.Berry, C.Lu, E.Tikkanen, S.Pilz, L.T.Hiraki, J.D.Cooper, Z.Dastani, R.Li, D.K.Houston, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013; 10:e1001383; PMID:23393431; http://dx.doi.org/10.1371/journal.pmed.1001383
32. C.Cipriani, J.Pepe, S.Piemonte, L.Colangelo, M.Cilli, S.Minisola. Vitamin d and its relationship with obesity and muscle. Int J Endocrinol 2014; 2014:841248; PMID:25161666; http://dx.doi.org/10.1155/2014/841248
33. J.Wortsman, L.Y.Matsuoka, T.C.Chen, Z.Lu, M.F.Holick. Decreased bioavailability of vitamin D in obesity. Amer J Clin Nutr 2000; 72:690-3; PMID:10966885
34. M.Maetani, G.Maskarinec, A.A.Franke, R.V.Cooney. Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women. Nutr Cancer 2009; 61:225-31; PMID:19235038; http://dx.doi.org/10.1080/01635580802455149
35. A.Matsunuma, T.Kawane, T.Maeda, S.Hamada, N.Horiuchi. Leptin corrects increased gene expression of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase and -24-hydroxylase in leptin-deficient, ob/ob mice. Endocrinology 2004; 145:1367-75; PMID:14657008; http://dx.doi.org/10.1210/en.2003-1010
36. S.S.Martin, A.Qasim, M.P.Reilly. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 2008; 52:1201-10; PMID:18926322; http://dx.doi.org/10.1016/j.jacc.2008.05.060
37. Centers for Disease Control and Prevention. Obesity Trends Among U.S. Adults Between 1985 and 2010; 2010. Available at http://www.cdc.gov/obesity/downloads/obesity_trends_2010.pdf
38. S.E.Makariou, E.N.Liberopoulos, A.P.Agouridis, A.Challa, M.Elisaf. Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels. J Cardiovasc Pharmacol Ther 2012; 17:382-6; PMID:22431864; http://dx.doi.org/10.1177/1074248412439470
39. E.N.Liberopoulos, S.E.Makariou, E.Moutzouri, M.S.Kostapanos, A.Challa, M.Elisaf. Effect of simvastatin/ezetimibe 10/10 mg versus simvastatin 40 mg on serum vitamin D levels. J Cardiovasc Pharmacol Ther 2013; 18:229-33; PMID:23288870; http://dx.doi.org/10.1177/1074248412470513
40. T.Sathyapalan, J.Shepherd, S.L.Atkin, E.S.Kilpatrick. The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover study. Diabetes Obes Metab 2013; 15:767-9; PMID:23356580; http://dx.doi.org/10.1111/dom.12074
41. U.Grober, K.Kisters. Influence of drugs on vitamin D and calcium metabolism. Dermatoendocrinol 2012; 4:158-66; PMID:22928072; http://dx.doi.org/10.4161/derm.20731
42. P.Sertznig, M.Seifert, W.Tilgen, J.Reichrath. Activation of vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling pathways through 1,25(OH)(2)D(3) in melanoma cell lines and other skin-derived cell lines. Dermatoendocrinol 2009; 1:232-8; PMID:20592797; http://dx.doi.org/10.4161/derm.1.4.9629
43. M.Kiss, Z.Czimmerer, L.Nagy. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology. J Allergy Clin Immunol 2013; 132:264-86; PMID:23905916; http://dx.doi.org/10.1016/j.jaci.2013.05.044
44. F.Alimirah, X.Peng, L.Yuan, R.R.Mehta, A.von Knethen, D.Choubey, R.G.Mehta. Crosstalk between the peroxisome proliferator-activated receptor gamma (PPARgamma) and the vitamin D receptor (VDR) in human breast cancer cells: PPARgamma binds to VDR and inhibits 1alpha,25-dihydroxyvitamin D3 mediated transactivation. Experimental Cell Research 2012; 318:2490-7; PMID:22884583; http://dx.doi.org/10.1016/j.yexcr.2012.07.020
45. H.Salamon, N.Bruiners, K.Lakehal, L.Shi, J.Ravi, K.D.Yamaguchi, R.Pine, M.L.Gennaro. Cutting edge: Vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection. J Immunol 2014; 193:30-4; PMID:24899504; http://dx.doi.org/10.4049/jimmunol.1400736
46. T.W.Dunlop, S.Vaisanen, C.Frank, F.Molnar, L.Sinkkonen, C.Carlberg. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol 2005; 349:248-60; PMID:15890193; http://dx.doi.org/10.1016/j.jmb.2005.03.060
47. A.B.Goldfine, C.R.Kahn. Adiponectin: linking the fat cell to insulin sensitivity. Lancet 2003; 362:1431-2; PMID:14602433; http://dx.doi.org/10.1016/S0140-6736(03)14727-7
48. D.V.Dudenkov, B.P.Yawn, S.S.Oberhelman, P.R.Fischer, R.J.Singh, S.S.Cha, J.A.Maxson, S.M.Quigg, T.D.Thacher. Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study. Mayo Clin Proc 2015; 90:577-86; PMID:25939935; http://dx.doi.org/10.1016/j.mayocp.2015.02.012
49. R.P.Heaney. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 2014; 72:48-54; PMID:24330136; http://dx.doi.org/10.1111/nure.12090
50. S.J.Lewis, I.Baker, G.Davey Smith. Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. Int J Tuberc Lung Dis 2005; 9:1174-7; PMID:16229232
51. I.G.Ovsyannikova, I.H.Haralambieva, R.A.Vierkant, M.M.O'Byrne, R.M.Jacobson, G.A.Poland. Effects of vitamin A and D receptor gene polymophisms/haplotypes on immune responses to measles vaccine. Pharmacogenet Genomics 2012; 22:20-31; PMID:22082653; http://dx.doi.org/10.1097/FPC.0b013e32834df186
52. A.E.Grzegorzewska, E.Jodlowska, A.Mostowska, A.Sowinska, P.P.Jagodzinski. Single nucleotide polymorphisms of vitamin D binding protein, vitamin D receptor and retinoid X receptor alpha genes and response to hepatitis B vaccination in renal replacement therapy patients. Exp Rev Vaccines 2014:13:1395-403
53. A.P.Ivanov, E.M.Dragunsky, K.M.Chumakov. 1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice. J Infect Dis 2006; 193:598-600; PMID:16425140; http://dx.doi.org/10.1086/499970
54. E.Y.Enioutina, D.Visic, Z.A.McGee, R.A.Daynes. The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant. Vaccine 1999; 17:3050-64; PMID:10462240; http://dx.doi.org/10.1016/S0264-410X(99)00147-4
55. R.A.Daynes, E.Y.Enioutina, S.Butler, H.H.Mu, Z.A.McGee, B.A.Araneo. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infection Immunity 1996; 64:1100-9; PMID:8606065
56. I.G.Ovsyannikova, S.J.White, R.A.Albrecht, A.Garcia-Sastre, G.A.Poland. Turkey versus guinea pig red blood cells: hemagglutination differences alter hemagglutination inhibition responses against influenza A/H1N1. Viral Immunol 2014; 27:174-8; PMID:24787023; http://dx.doi.org/10.1089/vim.2013.0111
57. World Health Organization. WHO Global Influenza Surveillance Network: Manual for the laboratory diagnosis and virological surveillance of influenza. 2011:1-139. Available at http://whqlibdoc.who.int/publications/2011/9789241548090_eng.pdf
58. S.D.Painter, I.H.Haralambieva, I.G.Ovsyannikova, D.E.Grill, G.A.Poland. Detection of Influenza A/H1N1-Specific Human IgG-Secreting B Cells in Older Adults by ELISPOT Assay. Viral Immunol 2014; 27:32-8; PMID:24605786; http://dx.doi.org/10.1089/vim.2013.0099